Life Sciences

The eight-week pilot program at WPS concluded in May.

Outdoor growers face a litany of hurdles to bring product to market, but the end result can be an environmentally friendlier option to indoor production.

Page will assist biopharmaceutical companies in navigating clinical and regulatory challenges to speed the delivery of innovative therapies.

A researcher at Worcester Polytechnic Institute is set to embark on a five-year project that seeks to advance the use of bacteria to help clean up contaminated soil, thanks to a $1.23-million grant from the National Science Foundation. 

Boston Scientific has added a new member to its board of directors, naming Dr. Cheryl Pegus as the board’s latest addition, effective immediately. 

A pair of lawmakers launched a Life Sciences Caucus Wednesday, adding another layer of Beacon Hill lobbying for the biopharma industry that appears likely to receive a third round of major financial support and tax incentives from the state under a proposal offered by Gov. Maura Healey.

The new facility, named the Operations and Manufacturing Center of Excellence, is a 32,000-square-foot facility that includes research and development, manufacturing, quality control, warehouse, and distribution space.

A warehouse near Interstate 190 in Worcester has been sold for $6.5 million to an entity associated with Biomedical Research Models, a Worcester-based, non-clinical contract research firm that conducts business as Biomere.

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics. 

The U.S. Food and Drug Administration has issued a recall of Boston Scientific’s Obsidio conformable embolic medical device after an investigation found using the product for lower gastrointestinal bleeding embolization can result in a high risk of bowel ischemia, otherwise known as reduced or restricted blood flow.